Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis

This study has been completed.

Study NCT00616538 Information provided by Ceragenix Pharmaceuticals

First Received: February 5, 2008 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	April 2007 (Final data collection date for primary outcome measure)